Related Experiment Video
Updated: Jan 2, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.3K
Recent Developments In Bronchial Thermoplasty For Severe Asthma.
1Institute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, UK.
Journal of Asthma and Allergy
|December 11, 2019
Summary
Bronchial thermoplasty offers modest effectiveness for severe asthma management after addressing other factors. Long-term safety is reassuring, but uncertainties remain regarding predictors of response and its precise role in treatment.
Area of Science:
- Pulmonology
- Respiratory Medicine
- Asthma Treatment
Background:
- Bronchial thermoplasty is an approved non-pharmacological treatment for severe asthma.
- Recent publications focus on patient selection, response predictors, and procedural advancements.
Purpose of the Study:
- To review recent literature on bronchial thermoplasty for severe asthma.
- To discuss patient selection, response predictors, effectiveness, mechanism, cost-effectiveness, and management role.
Main Methods:
- Review of recent publications on bronchial thermoplasty.
- Discussion of clinical practice data, mechanisms of action, and cost-effectiveness.
Main Results:
- Bronchial thermoplasty is an option for severe asthma after optimizing other treatments.
- Clinical practice outcomes are comparable to trials despite worse baseline characteristics.
- Potential mechanisms include airway smooth muscle reduction, epithelial/gland/nerve function changes, small airway improvement, or placebo effect.
Conclusions:
- Bronchial thermoplasty provides modest effectiveness for severe asthma post-optimization.
- Short-term morbidity occurs, but long-term safety is supported.
- Uncertainties persist regarding response predictors, mechanisms, and optimal management placement.
Related Concept Videos
01:24Chest Physiotherapy
1.3K
Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
1.3K
01:26Flail Chest-II
468
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
468
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:26COPD: Management Using Bronchodilators and Corticosteroids
679
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
679
01:17Drugs Used in Lower Respiratory Disorders: Overview
969
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
969
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
1.5K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.5K